Summary
A bioRxiv preprint reports elevated activation in virus-specific CD8 T cells from a subset of people with long COVID. The immune-cell profiles are consistent with persistent antigen stimulation, but provide an indirect signal rather than direct detection of viral antigens.
A bioRxiv preprint posted on October 16, 2026 reports that a subset of people with long COVID had persistently activated CD8 T cells targeting SARS-CoV-2 or Epstein-Barr virus (EBV). The researchers say the cells’ profiles are consistent with ongoing stimulation by viral antigens, offering an immune-cell signal of processes that have been difficult to detect directly.
The study profiled virus-specific T cells from hundreds of people with long COVID and recovered controls. The authors combined spectral flow cytometry, single-cell sequencing and peptide–HLA tetramers, which help identify T cells that recognise particular viral fragments presented by immune-system molecules called HLA.
What the immune-cell profiles showed
The researchers found elevated activation in CD8 T cells targeting SARS-CoV-2 spike protein and/or lytic antigens from EBV in a subset of participants with long COVID. They did not report the same pattern for the other viral specificities examined.
Spike-specific cells from people with long COVID also expressed genes associated with T-cell receptor stimulation, terminal effector differentiation and exhaustion. When researchers exposed the cells to their matching peptide outside the body, the cells showed reduced functionality. These findings describe an altered state in some virus-specific T cells; they do not mean that every person with long COVID has the same immune profile.
CD8 T cells normally recognise fragments of proteins displayed by HLA molecules and can respond to cells carrying those fragments. A persistent activation signature can therefore provide an indirect clue that a T cell is encountering its target. The researchers interpret the results as evidence that persistent SARS-CoV-2 antigens may be chronically stimulating T cells in some people with long COVID. Their approach uses the cells as biosensors; it is not direct detection of viral material in tissue or blood.
What the findings could add
Long COVID has been associated with proposed mechanisms including persistence of SARS-CoV-2 and reactivation of herpesviruses, but detecting viral antigens directly can be challenging. The study’s approach could help investigate antigen exposure by examining how virus-specific T cells respond. The authors suggest that this may inform research into long COVID and other disease settings, including the development of therapeutic strategies.
The work is a preprint, and its abstract describes a cohort of hundreds but does not give exact participant counts. The immune-cell findings support a possible link between persistent antigen stimulation and long COVID in a subset of people; whether that process causes symptoms or how it relates to individual disease courses remains unresolved.